This study was performed to evaluate the clinical risk profile of patients with ovarian tumors who were surgically treated, measuring the survival rate at 5 years. Furthermore, the surgical treatment by TNM stages was achieved, measuring the survival rate after five years of follow-up. Most of the patients with malignant disease were multiparous Moreover, from menopausal patients, the higher prevalence was seen at the group between 45 and 55 years old, not being dependent on the earlier appearance.
Держа треножник в одной руке, а свой контейнер - в другой, Хилвар стал спускаться по склону, Элвин же поспешал сзади, изо всех сил стараясь удержаться в круге света. Наконец, они разбили лагерь в небольшой ложбине в нескольких сотнях метров от вершины, и Хилвар занялся приведением в действие прочего снаряжения. Первой появилась большая полусфера из какого-то прочного и почти невидимого материала, полностью окутавшая их, защитив от начинающегося холодного ветра.
Купол, судя по всему, генерировался небольшим ящичком, который Хилвар кинул на землю, тут же полностью забыв о нем и даже забросав прочими пожитками. Возможно, из него же спроецировались комфортабельные полупрозрачные кушетки, на одной из которых Элвин с наслаждением растянулся.
The highest incidence of gynecological pathology was seen in women with polycystic ovaries i. Regarding serum CA tumoral marker, higher values were noticed in the majority of patients The highest prevalence of surgical treatment in the first and second stages was represented by total hysterectomy with bilateral anexectomy, omentectomy and peritoneal lavage, and for the third and fourth stages, total hysterectomy, bilateral anexectomy, omentectomy, peritonectomy and lymphadenectomy, with a better survival rate at five years seen in patients under the age of 30 years old.
Clinical risk profile associated with ovarian cancer
Thus, our study shows the need to create a screening for patients at risk for ovarian cancer which peritoneal cancer cure rate higher age, multiparity, early menarche, polycystic ovaries association, and higher serum CA marker values. The survival rate at five years of folow-up shows a higher incidence of survival in patients under 30 years old, probably due to the earlier stages detected.
Keywords malignant tumors, ovarian cancer, surgical treatment, management Rezumat Context. Acest studiu a fost efectuat pentru a evalua caracteristicile profilului de risc clinic al pacientelor cu tumori ovariene care au fost tratate chirurgical, măsurând rata de supravieţuire la cinci ani. Mai mult, a fost realizat tratamentul chirurgical prin etapele TNM, măsurând rata de supravieţuire după cinci ani de urmărire.
Mai mult, din de paciente la menopauză, prevalenţa crescută a fost observată la grupul cuprins între 45 şi 55 de ani, fără a depinde de precocitatea apariţiei. Prevalenţa crescută a tratamentului chirurgical în stadiile I şi II a fost reprezentată de histerectomie totală cu anexectomie bilaterală, omentectomie şi lavaj peritoneal, iar pentru stadiile III şi IV, de histerectomie totală, anexectomie bilaterală, omentectomie, peritonectomie şi limfadenectomie, cu o rată mai mare de supravieţuire la cinci ani la pacientele cu vârsta sub 30 de ani.
Riscul apariţiei tumorilor ovariene maligne este asociat mai mult cu vârsta, paritatea, menarha timpurie, asocierea ovarelor peritoneal cancer cure rate şi bazată pe stadializarea TNM.
Rata de supravieţuire la cinci ani ulterior arată o incidenţă mai peritoneal cancer cure rate a supravieţuirii la pacientele cu vârsta sub 30 de ani, probabil datorită detecţiei în stadiile incipiente.
Cuvinte cheie tumori maligne cancer ovarian tratament chirurgical management Introduction Being the leading cause of gynecological diseases, ovarian tumors are estimated peritoneal cancer cure rate the fifth cause of death among women 1. Many of the published studies are institutional-single center analyses which enrolled only peritoneal cancer cure rate small number of patients and the majority of reports were not relating to general population 7,8.
Although many studies have been published about ovarian tumors, only a few have analyzed the importance of the clinical factors implicated 9. And currently, only a limited number of studies regarding detailed surgical staging have been published, including the survival rate of younger women diagnosed with ovarian tumors Although for most of the early-detected cases the treatment consisted in total hysterectomy, infracolic omentectomy, peritoneal biopsy and lymph node extraction, maximal cytoreductive surgery remains the basic surgery treatment for advanced ovarian tumors Besides many other tumoral markers involved in diagnosis and prognosis of ovarian cancer, serum cancer antigen CA is generally used in the differentiation of other pelvic mases 16, This marker can be evaluated as a prognostic factor, before the initiation of any treatment However, the implication of peritoneal cancer cure rate CA levels in ovarian cancer prognostic is more controversial, considering other variabilies such as staging The present peritoneal cancer cure rate was undertaken on ovarian cancer patients, in which we proposed to determine the risk associated with age, parity, menarche and menopause peritoneal cancer cure rate, gynecological pathologies, serum CA tumoral marker, tumor, lymph node and metastasis TNM staging, and surgical treatment associated with improved five-year survival outcome.
Our study group consisted in patients with malignant ovarian tumors who were selected from a total of ovarian tumors which presented at peritoneal cancer cure rate one ovarian tumor formation with a 5-mm minimal diameter.
Directory of Research Journals Indexing
All patients underwent surgery peritoneal cancer cure rate primary treatment. The study was approved by our institution, and the informed consent from each patient was taken.
The inclusion criteria were as follows: age between 15 years old and more than 60 years old at the time of the initial diagnosis, all stages of ovarian neoplasms, and receiving only surgical treatment. We excluded women with a history of tubal sterilization techniques, pelvic radiation therapy either pre- or postoperatively, including pregnant women.
The characteristics were expressed in percentages.
Unfortunately, it does not have specific signs and symptoms, being associated with an aggressive evolution and a poor prognosis if left untreated. Their results suggest that PD-1 and Peritoneal cancer cure rate could be potential biomarkers for targeted treatment in some patients diagnosed with diffuse large B-cell lymphoma.
Descriptive statistics was used in order to correlate the data. Results Distribution by age Regarding the age of the patients, most malignant ovarian tumors were encountered in the age group over peritoneal cancer cure rate years old, follwed by year-old patients, with Table 1.
Distribution of cases with malignant ovarian tumors by age Parity of the patients Out of the studied women, Figure 1. Distribution of cases Age of menarche Malignant tumors occurred in patients Figure 2.
Distribution of cases with ovarian tumors depending Menopause precocity Of the cases analyzed, patients were menopausal, with the remaining 76 being in a younger age group. Out of these, 44 Figure 3.
Distribution of cases with ovarian tumors depending Association of gynecological pathology Malignant ovarian tumors were associated more with polycystic ovaries, in 13 patients 5. Table 2.
Distribution of ovarian cancers studied according to associated gynecological pathology Figure 4. Ovarian tumors, intraoperative aspects personal archive Figure 5. Intraoperative aspects in ovarian tumors personal archive Serum CA tumoral marker Only cases of malignant tumors were tested for serum CA tumor marker.
Out of these, Figure 6. The distribution of CA marker in the ovarian neoplasm in the study group TNM staging In stage I, there were 38 malignant ovarian tumors Stage II represented In the third stage, In the fourth stage, there were 49 malignant ovarian tumors Table 3. Distribution of ovarian cancer patients studied according to TNM staging Surgical treatment The therapeutic strategies have been chosen according to the TNM stage.
For stage Ia, unilateral anexectomy was chosen only under certain conditions. Adjuvant chemotherapy was not necessary in all cases.
Journal Volume Details
peritoneal cancer cure rate Second-look laparoscopy was practiced at six months per-pelviscopic and was addressed to patients who apparently responded fully to chemotherapy or just to surgical treatment. This allows an assessment of residual risk peritoneal cancer cure rate consolidation treatment, directing subsequent attitudes. Thus, the following intervention was generally performed for the first and second stages: total hysterectomy with bilateral anexectomy and omentectomy. Therefore, malignant ovarian tumors in the first and second stages of development have received the following surgical treatments according to the TNM peritoneal cancer cure rate unilateral anexectomy in 8.
Distribution of surgical treatment in the first and second stages of malignant ovarian tumo For the third and fourth stages, radical interventions were performed: hysterectomy with bilateral anexectomy with omentectomy, to which the large locoregional and visceral extensions could be added.
Ovarian cancers in the third and fourth stages were subjected to the following surgical interventions according to peritoneal cancer cure rate TNM stage: total hysterectomy with bilateral anexectomy, with omentectomy, with peritonectomy and lymphadenectomy in 86 cases Table 5.
- Profilul de risc clinic asociat cancerului ovarian
- Papillomavirus verruche genitali
- Cancer cerebral avancado
The age group counted 94 cases with ovarian cancer. Out of these, 50 patients Patients over the age of 60 wereof whom only 26 Discussion Many studies involving the clinical risk profile peritoneal cancer cure rate the malignant tumors are still in debate. Until present, many reports have showed the importance of younger age in the disease prognostic, with papilloma skin causes outcome and survival rates 5, In this respect, other studies have found opposite results, considering that age was not an independent factor after adjusting the tumor stage In the present study, we proposed to perform a large population-based study to evaluate the clinical characteristics between younger and older patients with malignant ovarian cancer.
Furthermore, we sought to show if younger age is an important factor for improved survival rate, among other features like parity, menarche and menopause, gynecological pathology association, serum CA tumoral marker, TNM staging, and surgical treatment.
In our study, the malignant tumors occurred in In this respect, one study among women peritoneal cancer cure rate reported lower risk with late age at menarche i. The inconsistent features regarding age at menarche and menopause could show differences and misclassification bias, or differences in study population